Thermogenesis Holdings Inc
F:THR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Thermogenesis Holdings Inc
Net Issuance of Common Stock
Thermogenesis Holdings Inc
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Thermogenesis Holdings Inc
F:THR
|
Net Issuance of Common Stock
$317k
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-25%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Issuance of Common Stock
$282m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
12%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Net Issuance of Common Stock
-$719.3m
|
CAGR 3-Years
20%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-5%
|
|
|
Stryker Corp
NYSE:SYK
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbott Laboratories
NYSE:ABT
|
Net Issuance of Common Stock
-$497m
|
CAGR 3-Years
36%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Issuance of Common Stock
-$1.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Thermogenesis Holdings Inc
Glance View
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 39 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for large scale cell manufacturing services. The company manufactures and markets three categories of products, Clinical Bio-Banking Applications, Point-of-Care Applications, and Large Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications includes AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Point-of-Care Applications includes PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory useand CAR-TXpress Platform for clinical manufacturing.
See Also
What is Thermogenesis Holdings Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
317k
USD
Based on the financial report for Mar 31, 2024, Thermogenesis Holdings Inc's Net Issuance of Common Stock amounts to 317k USD.
What is Thermogenesis Holdings Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-25%
Over the last year, the Net Issuance of Common Stock growth was -96%. The average annual Net Issuance of Common Stock growth rates for Thermogenesis Holdings Inc have been -73% over the past three years , -43% over the past five years , and -25% over the past ten years .
